Literature DB >> 16168853

A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer.

Kent A Gifford1, John L Horton, Christopher E Pelloski, Anuja Jhingran, Laurence E Court, Firas Mourtada, Patricia J Eifel.   

Abstract

PURPOSE: To determine the effects of Fletcher Suit Delclos ovoid shielding on dose to the bladder and rectum during intracavitary radiotherapy for cervical cancer. METHODS AND MATERIALS: The Monte Carlo method was used to calculate the dose in 12 patients receiving low-dose-rate intracavitary radiotherapy with both shielded and unshielded ovoids. Cumulative dose-difference surface histograms were computed for the bladder and rectum. Doses to the 2-cm(3) and 5-cm(3) volumes of highest dose were computed for the bladder and rectum with and without shielding.
RESULTS: Shielding affected dose to the 2-cm(3) and 5-cm(3) volumes of highest dose for the rectum (10.1% and 11.1% differences, respectively). Shielding did not have a major impact on the dose to the 2-cm(3) and 5-cm(3) volumes of highest dose for the bladder. The average dose reduction to 5% of the surface area of the bladder was 53 cGy. Reductions as large as 150 cGy were observed to 5% of the surface area of the bladder. The average dose reduction to 5% of the surface area of the rectum was 195 cGy. Reductions as large as 405 cGy were observed to 5% of the surface area of the rectum.
CONCLUSIONS: Our data suggest that the ovoid shields can greatly reduce the radiation dose delivered to the rectum. We did not find the same degree of effect on the dose to the bladder. To calculate the dose accurately, however, the ovoid shields must be included in the dose model.

Entities:  

Mesh:

Year:  2005        PMID: 16168853     DOI: 10.1016/j.ijrobp.2005.03.043

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Localizing intracavitary brachytherapy applicators from cone-beam CT x-ray projections via a novel iterative forward projection matching algorithm.

Authors:  Damodar Pokhrel; Martin J Murphy; Dorin A Todor; Elisabeth Weiss; Jeffrey F Williamson
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

2.  Influence of metal of the applicator on the dose distribution during brachytherapy.

Authors:  Chin-Hui Wu; An-Cheng Shiau; Yi-Jen Liao; Hsin-Yu Lin; Yen-Wan Hsueh Liu; Shih-Ming Hsu
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

3.  HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator.

Authors:  Chin-Hui Wu; Yi-Jen Liao; An-Cheng Shiau; Hsin-Yu Lin; Yen-Wan Hsueh Liu; Shih-Ming Hsu
Journal:  Sci Rep       Date:  2015-12-11       Impact factor: 4.379

4.  Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy.

Authors:  Primoz Petric; Robert Hudej; Noora Al-Hammadi; Barbara Segedin
Journal:  Radiol Oncol       Date:  2016-11-09       Impact factor: 2.991

5.  Comparison of a 3-D multi-group SN particle transport code with Monte Carlo for intracavitary brachytherapy of the cervix uteri.

Authors:  Kent A Gifford; Todd A Wareing; Gregory Failla; John L Horton; Patricia J Eifel; Firas Mourtada
Journal:  J Appl Clin Med Phys       Date:  2009-12-03       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.